|
Macular Degeneration
Citations 51-60 of 268 total displayed.
|
Past content
(since Jan 1998):
|
- Letters
An Ethical View of the Ranibizumab and Bevacizumab Controversy—Reply
- Raja Narayanan; Baruch D. Kuppermann
Arch Ophthalmol 2008; 126: 287.
[Extract]
[Full text]
[PDF]
- Epidemiology
Further Observations on the Association Between Smoking and the Long-term Incidence and Progression of Age-related Macular Degeneration: The Beaver Dam Eye Study
- Ronald Klein; Michael D. Knudtson; Karen J. Cruickshanks; Barbara E. K. Klein
Arch Ophthalmol 2008; 126: 115-121.
[Abstract]
[Full text]
[PDF]
- Letters
Participants and Methods in AREDS Report No. 8
- W. Rex Hawkins
Arch Ophthalmol 2008; 126: 146-147.
[Extract]
[Full text]
[PDF]
- Letters
Participants and Methods in AREDS Report No. 8—Reply
- Roy C. Milton; Traci E. Clemons; Emily Y. Chew
Arch Ophthalmol 2008; 126: 147.
[Extract]
[Full text]
[PDF]
- Clinical Trials
Improved Vision-Related Function After Ranibizumab Treatment of Neovascular Age-Related Macular Degeneration: Results of a Randomized Clinical Trial
- Tom S. Chang; Neil M. Bressler; Jennifer T. Fine; Chantal M. Dolan; James Ward; Todd R. Klesert; for the MARINA Study Group
Arch Ophthalmol 2007; 125: 1460-1469.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Incident Choroidal Neovascularization in Fellow Eyes of Patients With Unilateral Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: SST Report No. 20 From the Submacular Surgery Trials Research Group
- Submacular Surgery Trials Research Group
Arch Ophthalmol 2007; 125: 1323-1330.
[Abstract]
[Full text]
[PDF]
- Clinical Sciences
Intravitreal Bevacizumab vs Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration
- Ziad F. Bashshur; Alexandre Schakal; Rola N. Hamam; Christelle P. El Haibi; Rola F. Jaafar; Baha’ N. Noureddin
Arch Ophthalmol 2007; 125: 1357-1361.
[Abstract]
[Full text]
[PDF]
- Clinical Sciences
Long-term Follow-up of Macular Translocation With 360° Retinotomy for Exudative Age-Related Macular Degeneration
- Sabine Aisenbrey; Karl Ulrich Bartz-Schmidt; Peter Walter; Ralf Dieter Hilgers; Helen Ayertey; Peter Szurman; Gabriele Thumann
Arch Ophthalmol 2007; 125: 1367-1372.
[Abstract]
[Full text]
[PDF]
- Epidemiology
C-reactive Protein Level and Risk of Aging Macula Disorder: The Rotterdam Study
- Sharmila S. Boekhoorn; Johannes R. Vingerling; Jacqueline C. M. Witteman; Albert Hofman; Paulus T. V. M. de Jong
Arch Ophthalmol 2007; 125: 1396-1401.
[Abstract]
[Full text]
[PDF]
- Laboratory Sciences
Intravitreal Infliximab and Choroidal Neovascularization in an Animal Model
- Jeffrey L. Olson; R. Jackson Courtney; Naresh Mandava
Arch Ophthalmol 2007; 125: 1221-1224.
[Abstract]
[Full text]
[PDF]
|
|
